SARS-COV-2 Omicron

Jule Goike1,2, Ching-Lin Hsieh2, Andrew P Horton1,2,3

  • 1Center for Systems and Synthetic Biology, Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.

Communications biology
|December 11, 2023
PubMed
概括

一种强大的抗体 (N3-1) 通过结合所有尖端蛋白受体结合域来中和SARS-CoV-2变体. 设计改进有助于Omicron结合,但部分恢复了中和,为未来的疫苗开发提供了洞察力.